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1. Introduction 
Now, Gamma Knife radiosurgery (GKRS) is considered a first choice therapeutic option in a 
wide setting of malignant and benign intracranial diseases. Particularly, the application of 
GKRS in pilocytic (GI) and diffuse (GII) astrcytomas, which currently represent the most 
frequent brain neoplasms in children and young adults, has been often described. In the 
different series, the reported overall tumor growth control (TGC) varies between 50%-100%, 
the Overal Survival (OS) is 78.6%-100% with a 5-year local progression free survival (PFS) 
comprised between 88.9% and 97.4%. The GKRS-related permanent neurologic morbidity is 
generally less then 5% (0%-7%) (Kano et al., 2009a; Kano et al., 2009b; Boethius et al., 2002; 
Hadjipanayis et al., 2002a; Hadjipanayis et al., 2002b; Kida et al., 2000; Simonova et al., 2005; 
Heppner et al., 2005). Therefore, GKRS is considered an effective and safe therapeutic tool in 
the multidisciplinary treatment of pilocytic and diffuse astrcytomas, as well. Nevertheless, the 
effectiveness of GKRS is much less known as concerns other unusual Low-Grade Primitive 
Neuroepithelial Tumors (LGPNTs) of the brain because data regarding the long-term efficacy 
of GKRS on a large series of patients with such tumors is lacking. The aim of this chapter is to 
assess the value of GKRS in the management of such cerebral tumors. The interest of this study 
is founded on several observations: 1) unusual LGPNTs are rare tumours; there are a few 
series with at least ten reported cases, only (Hasegawa et al., 2002; Kim et al., 2007); 2) these 
tumors are frequently deep-seated in the brain or located in functional cerebral regions, thus 
gross total surgical removal may often be highly risky or impossible sometimes; 3) unusual 
LGPNTs are more frequent in children and young adult patients (Reyns et al., 2006; Yen et al., 
2007). Furthermore, the management of residual, recurrent or unresectable tumours represent 
a challenge for neurosurgeons and neurooncologists due to: 1) histotypes with frequently high 
radio- and chemo-resistance; 2) high risk of permanent delayed brain tissue radiation damage 
in often very young patients and with long life expectancy. The reason behind the increased  
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use of GKRS in unusual LGPNTs, also, is that the highly conformal treatment planning 
possible with this technique allows delivery of citotoxic dose of radiation to the target field 
while minimazing the dose delivered to neighboring vital structures. Hence, radiosurgery 
may be a less morbid alternative for treating deep-seated or functional-located lesions 
surrounded by eloquent structures. It therefore becomes possible to avoid toxic systemic 
side effects due to less effective antiblastic drugs, to preserve neurological function, to 
prevent further tumor growth and/or reinterventions in residual or recurrent tumors with 
remarkably low risks of acute radiation injury or delayed radiation therapy (RT)-related 
sequelae. In this chapter, the results of a retrospective study on 30 unusual LGPNTs of the 
brain treated with GKRS and followed up for at least 2 years will be presented and 
discussed. The end-points of this study will regard the OS, overall local TGC, actuarial 
Survival and local PFS (on the whole series and evaluated on different histologies) rates, and 
GKRS-related permanent side effects. Furthermore, a statistical analysis concerning the 
identification of potential prognostic factors influencing post-GKRS OS and local PFS among 
some selected independent variables will be performed, as well. 
2. Materials and methods 
2.1 Overall series 
Between February 1993 and February 2009, GKRS was performed on 30 patients (Table 1) 
with unusual LGPNTs of the brain (Grade I-II according to the WHO classification) (Louis et 
al., 2007). Inclusion criteria for GKRS included: lesions deep-seated in the brain or located in 
eloquent regions, histology confirmation, residual or recurrent tumors, tumor volume (TV) 
less than 15 cc, conditions of high operative risk, and patient refusal of microsurgery or 
reoperation. 
 
Histology N° Pt Age yr Surgery TV cc Pre-GK 
 M/F Mean (Range) /Biopsy Mean (Range) Treats. 
Overall series 16/14 38.4 (7-70) 20/10 4.9 (0.7-14.5) 
2 RT 
1 RT+Ch 
Pineocytoma 5/5 31.5 (7-58) 6/4 5.0 (0.8-11.7) 1 RT 
CPP 6/2 44.2 (22-70) 5/3 3.7 (0.7-9.9) 1 RT 
CN 1/3 33.2 (21-43) 4/0 6.5 (3.7-9.0) None 
PXA 1/2 48.0 (28-64) 2/1 7.3 (2.3-14.5) None 
Miscellaneous: 
Ganglioglioma 
Subependymoma 
Oligoastrocytoma 
Papillary Gl. Tum. 
2/3 19,2 (11-24) 3/2 3.7 (0.7-11.3) 1 RT+Ch 
N° Pt = number of treated patients; yr = year; TV = tumor volume; cc = cubic cm; Pre-GK Treats. = pre-
gamma knife treatments; M = male; F = female; RT = radiotherapy; Ch = chemotherapy; Papillary Gl. 
Tum. = papillary glioneuronal tumor. 
Table 1. Summary of clinical characteristics of 30 unusual LGPNTs treated with GKRS at 
University Hospital of Verona from February 1993 to February 2009. 
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The histologic types and grading were as follows: 10 pineocytomas (Grade I), 8 choroid 
plexus papillomas (CPP) (Grade I), 4 central neurocytomas (CN) (Grade II), 3 pleomorphic 
xanthoastrocytomas (PXA) (Grade II), 2 gangliogliomas (Grade I), 1 subependymoma 
(Grade I), 1 papillary glioneuronal tumor (Grade I), and 1 mixed oligoastrocytoma (Grade 
II). All tumors were histologically verified: 20/30 (67%) were surgical residuals or post-
operative recurrences, while biopsy confirmed the diagnosis in the remaining 10/30 cases: 4 
(13%) during neuroendoscopy approach and 6 (20%) with stereotactic brain intervention. 
There were 16 males and 14 females; the mean age of the clinical series was 34.7 years (7-70 
years). Further pre-GKRS treatments were as follows: RT alone, 2/30 patients (7%), and RT 
followed by chemotherapy, 1/30 (3%). The TV was always less than 15 cc. In 24/30 patients, 
pre-GKRS neurologic deficits were documented. The mean and range values of the 
radiosurgical dose planning parameters are summarized in Table 2. 
 
Histology  
Dose Plan 
Mean 
Parameters 
(Range)  
 PD Gy PI % ID mJ # Shots 
Overall series 16.5 (12-22.4) 50.2 (40-70) 104 (11.4-257.4) 9.6 (1-25) 
Pineocytoma 16.7 (13-20) 50.5 (50-55) 110.1 (18.9-257.4) 13.9 (5-25) 
CPP 15.1 (12-20.2) 48.7 (45-50) 72.9 (11.4.189.7) 7.1 (3-11) 
CN 16.4 (14-18) 47.5 (40-50) 151.6 (84.2-185.4) 7.0 (5-10) 
PXA 17.0 (13-20) 50.0 (50-50) 152.1 (69.6-248.5) 10.3 (2-25) 
Miscellaneous: 
Ganglioglioma 
Subependymoma 
Oligoastrocytoma 
Papillary Gl.Tum. 
18.2 (12.5-22.4) 54.0 (50-70) 74.4 (19.8-191.09 6.8 (1-16) 
PD = prescription dose; Gy = gray; PI = prescription isodose; ID = integral dose; mJ = milli Joule;  
# Shots = number of isocenters. 
Table 2. Summary of radiosurgical parameters of 30 unusual LGPNTs treated with GKRS at 
University Hospital of Verona from February 1993 to February 2009. 
The mean prescription dose (PD) was 16.5 Gy while the mean prescription isodose (PI) 
corresponded to 50.2%. The average value of integral dose (ID), parameter which describes 
the relationship between treated TV and delivered dose appropriately, was 104 mJ. The 
mean number of shots needed for dose planning was 9.6. Follow-up data, including causes 
of death, were obtained from hospital notes, imaging studies, and contact with relatives and 
family physicians. Medical records and MRI scans for all patients were carefully reviewed 
by neurosurgeons and neuroradiologists. This retrospective study was approved by the 
Ethical Commetee of our University Hospital. All patients identifiers were removed before 
data analysis. 
2.1.1 Pineocytoma 
In the group of pineocytoma, 7 out of 10 patients were young adults, under 40-year-old. 
Diagnosis was confirmed by bioptic samples harvest during a neuroendoscopic procedure 
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in 4 cases. In the other histologic groups, there were no patients in whom the histologic 
diagnosis was achieved following a neuroendoscopic intervention. The treated TV was 
always inferiour to 12 cc (mean, 5.0 cc). Only a 58-year-old woman, operated on in another 
institution, underwent RT following incomplete surgical removal. Neurologic deficits were 
present in 9/10 patients at the moment of GKRS. The 10 pineocytoma tumors were 
administered a radiosurgical dose comprised between 13 and 20 Gy with a mean PI of 50.5% 
and a mean ID of 110.1 mJ. The dose plannings for pineocytoma were particularly conformal 
as documented by the higher mean number of utilized isocenters (13.9) compared to the 
mean number of shots employed in the other histologic groups.   
2.1.2 Choroid plexus papilloma (CPP) 
The mean age in this group of patients was 44.2 years and most cases were males. The 
tumors were located in the following sites: 2 cerebellum, 2 ponto-cerebellar angle, 1 basal 
ganglia, 1 brain stem, 1 pineal region, and 1 skull base. Diagnosis was achieved by surgical 
intervention in 5 out of 8 cases. The TV treated with GKRS was always small, mean 3.7 cc, 
inferiour to the means of all the other histologic types of our series. In a 25-year-old man, 
two operations where performed before GKRS: the last histological examination confirmed a 
grade I CPP. Only in one case, RT was performed after partial surgical resection and before 
GKRS. All the patients complaint neurologic symptoms at last evaluation prior to GKRS. 
From the radiosurgical point of view, the mean PD and ID were lower than those of all the 
other histologic groups of our series, probably due to the highly critical brain location of 
most of these tumors.  
2.1.3 Central neurocytoma (CN) 
The mean age was 33.2 years. The tumor location was in the lateral ventricles in 2 cases, and 
one case in the basal ganglia and in the occipital lobe, respectively. Histologic diagnosis was 
defined by means of surgical intervention in all neoplasms. In 2 out of 4 patients, the pre-
GKRS neurologic evaluation was negative. The mean TV treated with radiosurgery was 6.5 
cc. None of the patients underwent to other treatments prior to GKRS. The mean PD and ID 
were 16.4 Gy and 151.6 mJ, respectively. 
2.1.4 Pleomorphic xanthoastrocyroma (PXA) 
Mean age and TV treated with GKRS (48.0 years and 7.3 cc, respectively) in this group of 
patients were higher than in the other groups of our series. Tumor lacations were as follows: 
1 brain stem, 1 temporal, and 1 temporo-occipital. In 2 cases, diagnosis was achieved by 
surgical intervention. In a 28-year old man affected with cystic right temporo-occipital PXA, 
a double stereotactic procedure was performed in the same neurosurgical session (Figure 1): 
first, an Ommaya reservoir was inserted for cyst aspiration; secondly, a biopsy of the tumor 
solid nodule for histopathological diagnosis definition was performed preceeded by 
changing of stereotactic coordinates and trajectory. All patients were symptomatic at the 
time of radiosurgery. No other treatment before GKRS was performed. Mean PD and ID 
delivered were higher than in the other groups of our series ( 17.0 Gy and 152.1 mJ, 
respectively). 
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A            B 
Fig. 1. A) 28-year old man with cystic temporo-occipital PXA. Calculation of stereotactic 
coordinates and trajectory for Ommaya reservoir insertion and tumor nodule biopsy. B) 
GKRS dose planning performed on shrinkaged tumor 10 days after double stereotactic 
intervention. 
2.1.5 Others (Miscellaneous) 
This group of patients included 2 gangliogliomas (Grade I), 1 subependymoma (Grade I), 1 
papillary glioneuronal tumor (Grade I), and 1 mixed oligoastrocytoma (Grade II). The mean 
age (19.2 years) was lower than in all the other groups. There were 2 males and 3 females. 
The tumor sites were as follows: 2 deep frontal, 1 basal ganglia, 1 occipital, and 1 third 
ventricle. There were 3 pre-GKRS surgical interventions and 2 stereotactic brain biopsies. In 
3 out of 5 patients, neurologic examination resulted negative on the day of radiosurgery. 
The mean TV treated with GKRS was 3.7 cc. A 24-year-old woman underwent stereotactic 
brain biopsy for a left frontal deep-seated tumor in another institution. Histologic diagnosis 
was grade II mixed oligoastrocytoma and a treatment protocol of RT and chemo-therapy 
was performed successively. In this group, the mean selected PI (54%) was higher than in all 
the other patient of our series. 
2.2 Radiosurgical technique and procedure 
Our radiosurgical technique was already described in detail in previous reports (Lunsford et 
al., 1989, Nicolato et al., 1997). In brief, after the application of the magnetic resonance 
imaging (MRI) compatible Leksell Model G stereotactic frame (Elekta Instruments AB, 
Stockholm, Sweden) to the patient's head, high resolution 1.0 Tesla MRI was performed in 
all cases. Millimetric volumetric images in axial and coronal orthogonal planes after 
gadolinium enhancement were used. First a sagittal MRI localizer or a 3-D scout survey 
(which included axial, coronal and sagittal images) were performed. Contrast enhanced 
Spoiled Gradient Recalled Acquisition in Steady State (SPGR) sequence was then used to 
image the tumor and surrounding brain. T2 weighted MR images using Fast Spin Echo 
technique also were acquired to assess the infiltrative tumor volume. The target volume 
included enhanced and non-enhanced tumor regions. Three-dimensional dose plans were 
developed by using commercially available software, i.e., Kula (Elekta Instruments) from 
February 1993 to February 1998 and Leksell Gamma Plan (versions 4.12, 5.34 and 8.3, Elekta 
Instruments) after February 1998. The neurological surgeon, radiation oncologist, and 
medical physicist created a highly conformal dose planning using multiple collimators and 
performed the dose selection. In all patients, the radiosurgery dose was prescribed to the 
entire tumor volume as defined using contrast enhanced imaging. GKRS was performed 
with either Model B, C 201-source Co60, or Perfexion Leksell Gamma Knife (Elekta 
Instruments). The procedure was performed under local anesthesia in 28/30 patients; 
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general anesthesia was administered in the two children younger than 14. All patients were 
discharged from the hospital within 24 hours after treatment, and they were evaluated 
clinically and with serial contrast-enhanced imaging using MRI at intervals of 6 months. The 
neurological status of the patient during the follow-up period was defined as no deficit pre-
GKRS, if the patient were without deficits before radiosurgery and remained clinically 
negative, improved, in case of complaint amelioration, stable or worsened. For the 
evaluation of TV, the mass lesion was measured by using the Gamma Plan software or the 
OsiriX medical imaging program (version 4.19) developed at the University Hospital of 
Geneva, Switzerland. Local TGC was defined as complete disappearance of enhancing and 
nonenhancing neoformation, lesion shrinkage or stable disease. 
2.3 Statistical analysis 
Survival and local PFS curves were calculated using the life-table system and the Kaplan–
Meier method (Kaplan & Meier, 1958). Length of survival and local PFS were evaluated on 
an actuarial basis from the day of GKRS treatment to the time of patient death or tumor 
progression and/or last follow-up, respectively. Survival and local PFS curves were 
compared and evaluated using Breslaw’s test (Breslaw,1974). We performed an univariate 
analysis using the log-rank test to detect variables that might influence the length of survival 
and local PFS. We matched the survival with four different variables, age, sex (male vs. 
female), histologic type (pineocytoma vs. choroid plexus papilloma vs. central neurocytoma 
vs. pleomorphic xanthoastrocytoma vs. miscellaneuos), prior surgical resection vs. biopsy, 
and the local PFS with seven different parameters, age, sex (male vs. female), histologic type 
(pineocytoma vs. choroid plexus papilloma vs. central neurocytoma vs. pleomorphic 
xanthoastrocytoma vs. miscellaneuos), prior surgical resection vs. biopsy, prescription dose, 
integral dose and length of follow-up. In Table 5, the statistical comparison between 
parameters in the different groups of patients were based on the Welch Modified Two-
Sample t-Test. On the basis of internationally accepted criteria, values of P ≤ 0.05 were 
considered statistically significant. Statistical analysis was effected using the Stata version 
8.2 (StataCorp, College Station, Texas) and MATLAB for graphics. 
3. Results 
3.1 Overall series 
The results of our series are summarized in Tables 3 and 4. The median duration of follow-
up was 66.8 months (range, 24.7-195.97 months). At the end of the study, February 28th, 
2009, the neurologic examination remained negative or showed an improvement of previous 
deficits in 16 patients, in 8 cases the complaints were stable and in the other 6 a worsening 
due to tumor progression was observed. Among these last patients, four were deceased. The 
cause of death was related to distant tumour progression in 2 cases and both to local and 
distant disease diffusion in the other 2 cases. The overall survival was 87%, and the actuarial 
survival rate at 5 and 10 years was 90% and 87%, respectively (Figure 2A). The median 
survival in the 4 patients who died was 50 months (range, 24.7-73 months) from GKRS. The 
local TGC was achieved in 27/30 (90%) tumors with a 91% local actuarial PFS both at 5 and 
10 years (Figure 2B). The median time to progression for the three patients with 
uncontrolled tumor was 18.5 months (range, 9.8-26.7 months). No GKRS-related permanent 
side-effect was observed on the whole series. To date, neither malignant tumor  
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Histology 
N° 
Pt Me/Med  
Clinical 
Results  
Alive/ 
Dead 
  FU mos. No def./Impr Stable Wors. (OS%) 
Overall series 30 85.7/66.8 16/30 8/30 6‡/30 26/4¶ (87.0) 
Pineocytoma 10 66.7/54.6 6/10 3/10 1/10 9/1 (90.0) 
CPP 8 92.6/71.8 2/8 2/8 4/8 6/2 (75.0) 
CN 4 172.0/180.6 4/4 – – 4/0 (100.0) 
PXA 3 45.6/43.7 1/3 1/3 1/3 2/1 (66.7) 
Miscellaneous 5 68.0/68.3 3/5 2/5 – 5/0 (100.0) 
N° Pt = number of treated patients with al least 2-year-follow-up; Me = Mean; Med = Median;  
mos. = months; No def./Impr = No pre-GK neurological deficit/Neurological improvement;  
Wors. = Neurological worsening; OS = Overall survival. 
‡: due to tumor distant progression in 4 cases and both to local and distant tumor diffusion in the other 
2 patients.  
¶: the cause of death was tumor distant progression in 2 cases and both local and distant tumor 
diffusion in the other 2 patients. 
Table 3. Summary of clinical results concerning 30 LGPNTs treated with GKRS at University 
Hospital of Verona from February 1993 to February 2009. 
 
Histology Act. Surv. % 
Ov. 
TGC%
Act. Local 
PFS% 
GK-related 
sequelae 
Post-GK 
treats. 
 
At 5y At 10y  At 5y At 10y Mort. Perm 
 Compl 
 
Overall series 90.0 87.0 90.0 91.0 91.0 0.0 0.0 
3 surg.int. 
1 VPS 
3 RT 
Pineocytoma 92.0 92.0 100.0 100.0 100.0 0.0 0.0 1 RT 
CPP 90.0 80.0 87.5 90.0 90.0 0.0 0.0 
1 surg.int. 
1 RT 
CN 100.0 100.0 75.0 83.0 83.0 0.0 0.0 
1 surg.int. 
1 RT 
PXA 80.0 80.0 66.7 80.0 80.0 0.0 0.0 1 VPS 
Miscellaneous 100.0 100.0 100.0 100.0 100.0 0.0 0.0 1 surg.int. 
Act. Surv. = Actuarial survival; Ov. TGC = Overall tumor growth control; Act. Local PFS = Actuarial 
local progression-free survival; Mort. = Mortality; Perm. Compl = Permanent Complications; Post-GK 
treats. = Post-GK treatments; surg.int. = surgical intervention; VPS = Ventricolo-peritoneal shunt;  
RT = Radiation therapy. 
Table 4. Summary of outcome results concerning 30 LGPNTs treated with GKRS at 
University Hospital of Verona from February 1993 to February 2009. 
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A B  
Fig. 2. Kaplan-Meier estimate of A) overall survival and B) local PFS curves in 30 LGPNTs. 
transformation nor GKRS-related mortality were registered. Post-GKRS treatments were 
represented by: 3 surgical removals, 1 ventriculo-peritoneal shunt and 3 fractionated 
irradiations. No chemotherapy treatment was performed on the whole series after GKRS. 
All variables tested at univariate analysis on the whole series did not show a statistically 
significant influence either as concerns survival or local PFS rates. In particular, the different 
histological type analized did not seem to have prognostic significance, as well (Figures 3A 
and 3B). Therefore, multivariate analysis was not performed. Nevertheless, a positive trend 
for PD and ID seems to emerge from statistical analysis (Table 5): in the 3 patients with local 
progression, the mean dose delivered to the periphery of the neoplasms was lower  
 
A  B  
Fig. 3. Kaplan-Meier estimate of A) overall survival and B) local PFS curves after GKRS for 
histologic types (P = NS). 
GKRS outcome N° Pt Mean TV
(cc) 
P value Mean PD
(Gy) 
P value Mean ID (mJ) P value 
Local TGC 27 4.61  16.8  98.74  
   <0.55  = 0.138  = 0.141 
Local Progr. 3 7.30  14.0  151.1  
N° Pt = number of treated patients; TV = tumor volume; cc = cubic cm; PD = prescription dose; Gy = 
gray; ID = integral dose; mJ = milli Joule. 
Table 5. statistical comparison between radiosurgical outcome and TV, PD, and ID in 30 
LGPNTs treated with GKRS.  
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(14.0 Gy) than that of the 27 tumors with local TGC (16.8 Gy), and the mean ID was higher 
(151.1 mJ) compared to that of the group under control (98.74 mJ). Because the ID is the 
result of volume multiplied by average dose, we evaluated the mean TV between the groups 
of patients with under control vs. progressed neoplasms, as well. The 3 patients with tumor 
progression presented a mean TV of 7.3 cc versus 4.6 cc of the tumors with favourable 
response. Even though the statistical analysis did not shaw significant results, the 
considerable difference of the two mean TV values authorizes to think that a possible 
correlation between TV and local TGC after GKRS could be proposed. Finally, it must be 
considered that the small number of observations might represent a bias for the statistical 
analysis. 
3.2 Pineocytoma 
In this group of patients, the median observation time was 54.6 months (range, 25.3-130.0 
months). On last follow-up day, 9 out of 10 patients were neurologically stable or improved 
(Table 3); only a 16-year-old boy worsened because of distant tumor progression and 
underwent post-GKRS RT, but unfortunately he died at 42 months from radiosurgery (OS, 
90%). All the other patients did not needed further treatments following GKRS. In the whole 
ten pineocytomas of our series, local TGC was achieved (overall TGC, 100%) (Figure 4). The 
5 and 10 year actuarial survival and local TGC were 92% and 100%, respectively (Table 4). 
     
A          B                C 
Fig. 4. A) Posterior III ventricle pineocytoma on GKRS day. The diagnosis was achieved by 
means of stereotactic neuroendoscopy biopsy. B) MR imaging follow-up at 3 months and C) 
at 18 months from GKRS showing the gradual disappearance of the tumor.   
3.3 Choroid plexus papilloma (CPP) 
The 8 patients of this group were followed-up for 71.8-month median time. A neurologic 
deterioration was observed in 4 patients: in 3 cases, due to tumor distant progression, and in 1 
both to local and distant progression. During the follow-up period, 2 of these last patients 
died: 1 because of tumor distant progression and 1 due to local and distant progression (OS, 
75%). The 5- and 10-year actuarial survival rates were 90% and 80%, respectively. Local TGC 
was reported in 7 patients (87.5%), with an actuarial local TGC of 90% both at 5- and 10-years. 
The 2 patients with distant progression refused further treatments: one of them is died at 57.7 
months from GKRS, and the other is still alive with mild neurologic deficits 181.7 months after 
radiosurgery. The treatments performed after GKRS were surgical intervention for local tumor 
progression in one case and RT in another patient with distant progression. 
3.4 Central neurocytoma (CN) 
The median follow-up period was 180.6 months (range, 142.7-183.9 months). At last 
observation, all patients were neurologically intact or clinically improved. The OS and the 5- 
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and 10-year actuarial survival rates were 100% (Table 4). The local TGC was achieved in 3 
out of 4 cases (75%) and the actuarial local TGC was 83% both at 5- and 10-years. In a 26-
year-old woman with a TV at radiosurgery of 9.0 cc was decided to associate RT after GKRS. 
She is alive and well at 177.3 months from radiosurgery. A surgical intervention was needed 
in a 21-year-old man because of local progression of an intraventricular residual tumor at 9.8 
months after GKRS. He underwent radiosurgery for a 5.9 cc  neoplasm and the administered 
PD was 14.0 Gy, the lowest value than in all the other patients treated for central 
neurocytoma.  
3.5 Pleomorphic xanthoastrocyroma (PXA) 
The median follow-up time in this group of patients was 43.7 months (range, 25.1-70.9 
months). At the end of the study, one patient showed an improvement of the neulogic 
complaints, the second was clinically stable and the third presented a gradual deterioration 
due to a brain stem tumor progression and died 25.1 months after GKRS. This patient was 
already operated prior to radiosurgery. She refused further RT and the only possible 
treatment was VPS. In this group, the OS and the local TGC rates were 66.7% and the 
actuarial survival and local TGC rates were 80% both at 5- and 10-years (Figure 5).    
 
Fig. 5. Same case than in figures 1. MRI follow up at 32 months from GKRS showing a 
significant tumor reduction. 
3.6 Others (Miscellaneous) 
The median period of follow-up was 68.3 months (range, 27.5-109 months). All patients in 
this heterogeneous group of unusual LGPNTs showed a negative, improved or stable 
neurological status at last observation (OS 100%), with an actuarial survival rate at 5- and 
10-years of 100% and 100%, respectively. All tumors treated with GKRS were under control 
(Table 4). A 24-year-old woman affected with a grade II mixed oligoastrocytoma and treated 
prior to radiosurgery with RT and chemotharapy elsewhere developed an expansive lesion 
with mass effect in left frontal region, far from the target volume treated with GKRS. 
Surgical removal was needed and histologic examination showed that it deals with 
radionecrosis, secondary to the previous RT. Now, she is well at 68.3 months from 
radiosurgery. She was the only patient in this group who needed a further treatment after 
GKRS. 
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4. Discussion 
4.1 Overall series 
Several series describing the results of stereotactic radiosurgery on LGPNTs of the brain 
including a large number of patients have been reported. However, they always dealt with 
low-grade gliomas. Kida (Kida et al., 2000) and Heppner (Heppner et al., 2005) presented 
their experience with GKRS on 51 and 49 patients with grade I and II astrocytomas, 
respectively. Hadjipanayis (Hadjipanayis et al., 2002a) treated 37 pilocytic astrocytomas of 
every age, and, more recently, Kano (Kano et al., 2009b) described the outcome following 
GKRS in 50 pilocytic astrocytomas in pediatric age, exclusively. Simonova (Simonova et al., 
2005) reported a series of 70 cases including different types of grade I and II gliomas in 
whom stereotactic radiosurgery was applied. Sarkar (Sarkar et al., 2002) and Kano (Kano et 
al., 2009c) reported two GKRS studies on 18 and 30 patients affected with 
oligodendrogliomas and mixed oligodendroastrocytomas, respectively, but both series 
included low- and high-grade tumors. As concerns the unusual primitive neuroepithelial 
tumors of the brain, the largest published series always comprised low- and high-grade 
tumors (Kano et al., 2009d, Mori et al., 2009, Lekovic et al., 2007, Hasegawa et al., 2002, 
Kobayashi et al., 2001), while the studies with exclusively unusual LGPNTs were always 
represented by a few cases (usually, less than 15). To our knowledge, the work of our team 
represent the largest series of unusual LGPNTs treated with stereotactic radiosurgery. In a 
study performed on 10 patients (8 pineocytoamas, 1 CPP, and 1 CN), Lekovic (Lekovic et 
al., 2007) reported an overall survival of 90%, a 100% local TGC, with neither GKRS-related 
mortality nor permanent morbidity. But, the patients were observed for a median period of 
less than 2 years (20.5 months). Our results obtained on 30 patients followed up for at least 
2 years (median, 66.8 months; range, 24.7-195.97 months) confirmed this excellent outcome. 
In brief, the 5- and 10-year actuarial survival rates were 90% and 87%, respectively, with a 
91% actuarial local PFS both at 5- and 10-year. The median time to progression for the three 
patients with uncontrolled tumor was 18.5 months and the median survival in the 4 
patients who died was 50 months. In 2 of them, the cause of death was exclusively due to 
tumor distant progression. Also in our series, no complications were attributable to GKRS. 
The only study on a series of LGPNTs in which was performed an analysis of potential 
prognostic factors influencing GKRS outcome is referred to Sarkar (Sarkar et al., 2002). The 
authors studied a series of 18 patients with 21 tumors – 10 oligodendrogliomas and 11 
mixed oligoastrocytomas – and found that factors associated with an improved survival 
rate included younger age and smaller tumors. In our series, univariate analysis on 
selected independent variables did not show any factors of significance. Nevertheless, we 
observed that patients with local TGC presented a smaller mean TV (4.61 cc vs. 7.0 cc), a 
higher mean PD (16.8 Gy vs. 14.0 Gy), and a lower mean ID (98.74 mJ vs. 151.1 mJ) than 
those with tumor progression. This trend could suggest that multisession GKRS with the 
Extend System (Elekta Instrument) should be better in those patients affected with larger 
tumors, thus achieving an increased dose delivery to the target volume maintaining a 
negligible risk of permanent side effects on the surrounding normal brain tissue. Some 
authors (Kobayashi et al., 2001, Kim et al., 2007) propose GKRS as primary treatment 
without histological diagnosis when a deep-seated or critically located brain tumor 
showing the imaging characteristics of an unusual LGPNTs is identified. On the contrary, 
other collegues state that obtaining a histological diagnosis remains the main aim for 
rational treatment planning (Matsunaga et al., 2010; Martin et al., 2003; Yen et al., 2007; 
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Tyler-Kabara et al., 2001; Kano et al., 2009d; Lekovic et al., 2007; Reyns et al., 2007; 
Dershmukh et al., 2004). In our series,all tumors were histologically verified before GKRS. 
We do not believe that empirical treatment of brain tumors with radiosurgery is justified, 
as the treatment paradigm is critically dependent upon tumor histological grade. 
Therefore, it is of paramount importance to achieve the histological diagnosis for decision 
making prior to GKRS. We suggest the use of radiosurgery as a primary treatment 
modality for those patients in whom an adeguate tissue diagnosis of an unusual LGPNTs 
has been obtained with endoscopy or stereotactic biopsy.  
4.2 Pineocytoma 
Pineal region tumors are rare and account for 0.4 to 1% of intracranial tumors in Western 
countries and for 2.2 to 8% of intracranial tumors in northeastern Asian countries 
(Deshmukh et al., 2004). They are 10 times more common in children than in adults. 
According to the statistics of the Brain Tumor Registry of Japan, pineal parenchimal tumors 
such as pineocytoma or pineoblastoma account for 7% of all pineal region tumors 
(Kobayashi et al., 2001). Individual clinical experience of these tumors is thus limited. 
Pineocytoma is tipically localized to the pineal area and compresses adjacent structures, 
including the cerebral acqueduct, brain stem and cerebellum. Their growth may extend into 
the third ventricle. The majority of patients exhibit neuro-ophtalmologic findings, 
particularly Parinaud syndromes (Grimoldi et al., 1998). MRI findings such as enhancement, 
calcification, and welldefined margins are suggestive of a pineocytoma but are by no means 
diagnostic (Chiechi et al., 1995). Therefore, tissue diagnosis is imperative. Pineocytoma is a 
slowly growing tumor with a relatively favorable prognosis in most cases. According to the 
2007 classification, pineocytomas correspond histologically to WHO grade I. From the 
pathological point of view, pineocytomas tend to recapitulate the normal pineal gland (Shild 
et al., 1996) (Figure 6). Despite improved microsurgical technique, resection of pineocytoma 
 
 
Fig. 6. Pineocytoma. X200 H-E. Classical morphological appearance of uniform cells with 
rosette and trabeculae. 
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remains a challange because of their deep location and associated critical structures. The 
surgical major morbidity rate associated with pineocytomas is comprised between 3% and 
6.8%, and permanent minor morbidity rate was 3-28%. The risk of surgical mortality 
associated with pineocytoma removal has been reduced in these last 20 years, but it remains 
less than 2% (Friedman et al., 2001, Bruce & Ogden, 2004). The role of adjuvant RT has not 
been clearly delineated. Furthermore, pineacytomas are traditionally considered 
radioresistant tumors. For all these reasons, the use of radiosurgery in the treatment of 
pineocytoma is more and more growing and diffusing worldwide and studies reporting the 
experience of different institutions are now available (Table 6). The first and more relevant 
published series always regard treatment performed with GK device. The median follow-up 
period varies between 11.0 and 73.5 months. Neither neurological worsening nor GKRS-
related permanent complications were reported. In our studies, 10 patients were followed 
up for a median period of 54.6 months; we observed a clinical worsening in 1 case, only, due 
to distant tumor progression. As concerns outcome results (Table 7), the overall survival 
Author RS 
dev
N° 
Pt 
Me/Med FU 
mos.  
Clinical 
Results  Sympt. Compl. 
    
No def. 
/Impr 
Stable Wors. Trans.     Perm. 
%            % 
Kano 2009† GK 13 54.1 Me 66.7       – – 23.0        0.0 
Mori 2009* GK 5 49.0/33.5 –          – – 0.0         0.0 
Lekovic 2007¶ GK 8 17.4/11.0 –         – – 0.0         0.0 
Reyns 2006 GK 7 31.7/37.0 –          – – –            – 
Desmukh 
2004¶ 
GK 3 19.3/12.0 –          – – –            – 
Hasegawa 
2002† 
GK 10 69.1/73.5 –          – – 10.0       0.0 
Kobayashi 
2001* 
GK 3 21.7 Me – – – –           – 
Subach 1998† GK 8 – – – – –           – 
Backlund 1974 GK 2 –             – – –      –           – 
Present series GK 10 66.7/54.6 6/10 3/10 1/10‡ 10.0       0.0 
RS dev = Radiosurgical device; N° Pt = number of treated patients; Me = Mean; Med = Median;  
mos. = months; No def./Impr = No pre-GK neurological deficit/Neurological improvement; 
Wors. = neurological worsening; Sympt. Compl. = Symptomatic complications; Trans. = transient; 
Perm. = Permanent; GK = Gamma Knife.  
†: Departments of Neurological Surgery and Radiation Oncology, The University of Pittsburgh, and 
Center for Image-Guided Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, Pa., USA.  
*: Nagoya Radiosurgery Center, Nagoya Kioritsu Hospital, and Gamma Knife Center, Komaki City 
Hospital, Komaki, Japan.  
¶: Division of Neurological Surgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical 
Center, Phoenix, Arizona, USA.  
‡: due to tumor distant progression. 
Table 6. Clinical data in previous and present series of pineocytomas treated with GKRS.  
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Author N° Ov. Surv. Act. Surv. % Ov. Local Act. Local  PFS% 
 Pt % At 5y  At 10y TGC% At 3y At 5y At 10y 
Kano 2009† 13 – 92.3       – 100.0 100.0 100.0 – 
Mori 2009* 5 – 100.0    67.0 80.0 – 85.0 – 
Lekovic 07¶ 8 87.5 –          – 100.0 –       – – 
Reyns 2006 7 100.0 –          – 100.0 – – – 
Desmukh 04¶ 3 – –          – 100.0 – – – 
Hasegawa 
2002† 
10 90.0 –          – 100.0 – – – 
Kobayashi 2001* 3 100.0 –          – 100.0 – – – 
Subach 1998† 8 – –          – 100.0 – – – 
Backlund 1974 2 –          –          –         100.0 –       – – 
Present series 10 90.0 92.0   92.0 100.0 – 100.0 100.0 
N° Pt = number of treated patients; Ov. Surv. = Overall survival; Act. Surv. = Actuarial survival;  
y = years; Ov. Local TGC = Overall local tumor growth control; Act. Local PFS = Actuarial local 
progression-free survival.  
†: Departments of Neurological Surgery and Radiation Oncology, The University of Pittsburgh, and 
Center for Image-Guided Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, Pa., USA.  
*: Nagoya Radiosurgery Center, Nagoya Kioritsu Hospital, and Gamma Knife Center, Komaki City 
Hospital, Komaki, Japan.   
¶: Division of Neurological Surgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical 
Center, Phoenix, Arizona, USA. 
Table 7. Radiosurgical outcome in previous and present series of pineocytomas. 
ranged between 87.5% and 100%. Mori (Mori et al., 2009) is the only author who reported 
a 10-year actuarial survival rate of 67%. In our series, the 10-year actuarial survival rate 
was 92%. The  local TGC and PFS were excellent in all published studies. Among 5 cases 
with a median follow-up of 33.5 months, Mori (Mori et al., 2009) reported that the tumors 
were controlled in 4 cases. Only one patient developed cerebrospinal fluid dissemination 
after GKRS. Lekovic (Lekovic et al., 2007) described only 1 death in a series of 8 
pineocytomas. The patient died 2 months after GKRS; however, MR images obtained 
immediately before the patient’s death showed a 75% reduction in the size of the lesion. 
Kano (Kano et al., 2009d) reported a 5-year local PFS rate of 100% in 13 pineocytomas 
observed for a median period of 54.1 months. Reyns (Reyns et al., 2006) treated 8 
pineocytomas and in 7 of them a follow-up period was available (median, 37.0 months). 
The author reported a 100% rate of overall survival and local TGC and he suggested that 
GKRS may represent a useful therapeutic modality in selected cases of pineal 
parenchymal tumours as part of a multidisciplinary approach. Our data achieved on a 
series with long term observation period strengthen the extremely encouraging  results 
already published. Hence, GKRS has showed to be a valid, effective and safe treatment 
modality in benign tumors with critical surgical approach and considered relatively 
radioresistant to conventional fractionated RT, such as the pineocytoma. The excellent 
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radiosurgical outcome is still present in long-term studies, as well. Therefore, we conclude 
that GKRS must be taken into account when considering the treatment management of 
pineocytoma, also as a primary choice in selected patients providing that a previous 
histopathological diagnosis is assured. 
4.3 Choroid plexus papilloma (CPP) 
CPPs are epithelial tumors of the choroid plexus that account for <1% of adult brain 
tumors (Kim et al., 2008). The majority occur within the ventricular system, the lateral 
ventricle being the most frequent location in children and the IVth ventricle in adults. The 
usual MRI findings are characterized by large, circumscribed, contrast-enhanced 
intraventricular tumor with occasional cyst formation and associated hydrocephalus. 
Tumoral calcification may be seen on plain radiographs. CPPs are slow-growing, 
epithelial tumors of the choroid plexus defined as grade I according to the WHO 
classifacation. Microsurgical resection is the preferred management for these tumors. 
Gross total resection is expected to be curative, with infrequent recurrence (Krishnan et 
al., 2004). However, complete resection is not always possible because CPPs have a deep-
seated location, close proximity to critical structures (e.g. brain-stem), florid vascularity, 
and capacity for local invasion into underlying brain parenchyma (Krishnan et al., 2004). 
Furthermore, microsurgery-related permanent complications are not negligible with 
morbidity and mortality rates up to 25% and 16.7%, respectively (Talacchi et al., 1999). 
Acute postoperative complications were frequent, most notably a 22% incidence of 
temporary swallowing dysfunction. This condition often led to placement of a 
percutaneous endoscopic gastrostomy tube or tracheostomy for aspiration, or both 
(Krishnan et al., 2004). Therefore, additional options for treatment resistant residual or 
recurrent tumors are needed. Additional management options in grade I CPP include 
repeat surgery and RT. Krishman (Krishman et al., 2004) noted that irradiation after 
subtotal resection was associated with a failure of local tumor control in one half of 
patients. They concluded that conventional fractionated RT after initial subtotal resection 
did not improve outcomes. The use of stereotactic radiosurgery for CPP has been 
described rarely. To date, there are 9 cases reported, only (Tables 8 and 9). Duke (Duke et 
al., 1997) published the first case of a third-ventricle CPP who underwent radiosurgery 
with an excellent neurologic and imaging result. Eder (Eder et al., 2001) reported one case 
of CPP in pediatric age with TV shrinkage following GKRS. Also Lekovic (Lekovic et al., 
2007) reported one case with partial response at 95 months from radiosurgery. To date, 
the most numerous published series goes back to Kim (Kim et al., 2008), who treated with 
GKRS 11 locally or distant recurrent intracranial CPPs in 6 patients. He described rates of 
overall survival and local TGC of 66.7% and 36.4%, respectively, but the study included 
some aggressive tumors, also. To our knownledge, the present is the largest series ever 
reported before regarding 8 patients affected with intracranial CPP and treated with 
radiosurgery. They were followed up for a median period of 71.8 months; the 5-year 
actuarial survival and local PFS rates were 90% and 90%, respectively. Even though the 
number of reported patients is limited, the long lasting TGC in most cases without GKRS-
related permanent side effects strongly suggests that radiosurgery could represent a valid 
alternative for the treatment of intracranial CPP, especially in resistant tumors, thus 
avoiding invasive and high risk repeated microsurgery and the potential long term 
neuropsychological sequelae associated with fractionated RT.  
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Author RS 
dev 
N° 
Pt 
Me/Med FU 
mos.  
Clinical 
Results  
Perm. 
Sympt.  
    No def. /Impr Stable Wors. Compl. 
Kim 2008 GK 6 57.3/55.5 – – – – 
Lekovic 2007 GK 1 96.0 – – – 0.0 
Eder 2001 GK 1 – – 1 – 0.0 
Duke 1997 GK 1 17.0 Excellent – – 0.0 
Present series GK 8 92.6/71.8 2/8 2/8 4/8‡ 0.0 
RS dev = Radiosurgical device; N° Pt = number of treated patients; Me = Mean; Med = Median;  
mos. = months; No def./Impr = No pre-GK neurological deficit/Neurological improvement; 
Wors. = Neurological worsening; Perm. Sympt. Compl. = permanent symptomatic complications;  
GK = Gamma Knife. 
‡: 3/4 due to tumor distant progression and 1/4 due to local and distant progression. 
Table 8. Clinical data in previous and present series of CPP treated with GKRS. 
Author N° 
Pt 
Ov. 
Surv. Act. Surv. % Ov. Local  Act. Local PFS% 
  % At 5y  At 10y TGC% At 5y       At 10y 
Kim 2008 6 66.7 –        – 
36.4 (with some aggressive 
tumors) 
–             – 
Lekovic 2007 1 100.0 –        – 100.0 –             – 
Eder 2001 1 100.0 –        – 100.0 (Ped. Pt.) –             – 
Duke 1997 1 100.0 –        – 100.0 –             – 
Present 
series 
8 75.0‡ 90.0      80.0 87.5 90.0         90.0 
N° Pt = number of treated patients; Ov. Surv. = overall survival; Act. Surv. = actuarial survival;  
Ov. Local TGC = overall local tumor growth control; Act. Local PFS = Actuarial local progression-free 
survival; Ped. Pt. = Pediatric patient. 
‡: 2 deaths: 1 due to tumor distant progression and 1 due to local and distant progression. 
Table 9. Radiosurgical outcome in previous and present series of CPP. 
4.4 Central neurocytoma (CN) 
CN was characterized by Hassoun (Hassoun et al., 1982) in the 1980's as a distinct 
histological entity with a typical immunohistochemical profile and ultrastructural features 
of neuronal differentiation. CN accounts for approximately 0.1% of all the primary CNS 
tumors and it is a typically disease of young adulthood, occurring in the second and third 
decades of life (Matsunaga et al., 2010; Tyler-Kabara et al., 2001). This unusual LGPNT 
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usually arise from the neuronal cells of the septum pellucidum, fornix, or subependymal 
plate of the lateral and third ventricle, so these tumors are surrounded by cerebrospinal 
fluid and occur as a small tumor attached to normal structures. CN is defined as grade II 
according to the WHO classification. This neoplasm is generally considered a benign, slow-
growing tumor. Histological study shows a pattern composed of uniform small round cells, 
usually with clear cytoplasm and round nuclei (Figure 7). Its features match those of 
oligodendroglioma or ependymoma, leading to frequent misdiagnosis when further 
investigations are not performed. Immunohistochemistry is very useful for the diagnosis of 
neurocytoma, which shows a dot-like positivity for synaptophysin, negativity for glial 
fibrillary acidic protein and constant expression of neuron-specific enolase (Martin et al., 
2003). Typical neurocytomas are characterized by a MIB-1 labeling index ≤3% and the 
absence of histologic atypia (Rades & Schild, 2006). Standard initial treatment for CNs is a 
total resection whenever possible. The prognosis is usually favorable after gross total 
resection, generally leading to cure and long-term survival. Furthermore, tumor resection 
not only provides a histological diagnosis but also restores the intracranial cerebrospinal 
fluid circulation. But, tumors in more than half of patients with CN cannot be completely 
resected. Furthermore, recurrences, even after complete resection, and tumor progression 
after subtotal resection have been reported up to 33% of cases (Matsunaga et al., 2010, Kim 
et al., 2007, Yen et al., 2007, Martin et al., 2003, Cobery et al., 2001). Finally, malignant 
transformation is known to occur in a few cases, resulting in tumor progression, 
intracerebral hemorrhage, or craniospinal dissemination (Matsunaga et al., 2010). For 
treatment of residual or recurrent CNs, fractionated RT has been advocated because these 
tumors tend to have high radiosensitivity due to their high vascularity. The results showed 
effective local tumor control. However, because of the benign clinical course of CN, the 
young mean age of the affected patients and the well-known long-term adverse effects of 
conventional RT, such as cognitive dysfunction and secondary tumor formation, routine use 
of conventional RT for residual or recurrent CN has been critized by several authors (Kim et 
al., 2007, Yen et al., 2007, Martin et al., 2003). The advantage of a focused radiation is that a  
 
 
Fig. 7. CN: X100 H-E. Olicodendroglial like cells with round nuclei and clear haloes. 
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high dose with a steep fall off in radiation can be delivered precisely in one single treatment 
session. In addition, the residual or recurrent CNs are usually characterised by highly 
vascularized and well demarkated small volumes with generally intraventricular growth; 
therefore, they tend to be surrounded by CSF, and only a small part of the tumor has contact 
with the brain tissue. This makes them ideal targets for GKRS, as most of the dose surplus 
hits the CSF and the radiation burden to the neighbouring brain tissue can be kept at a 
minimum. In this way, the side effects of radiosurgery are minimised. All these advantages 
have led to the emergence of GKRS as an attractive alternative to conventional RT in the 
treatment of residual or recurrent CNs. The first CN patient treated with radiosurgery was 
described by Schild (Schild et al., 1997) in 1997. Since 1997, several studies of CNs treated 
with radiosurgery have demonstrated good response and high TGC. The mechanism of 
tumor response to GKRS is not yet clear. Several hypothesis have been formulated to 
explain the TV shrinkage: 1) cytotoxic effect; 2) accelerated programmed cell death; or 3) 
obliteration of nutritive vessels (Yen et al., 2007). The latter was reported by Kulkarni 
(Kulkarni et al., 2002) after they observed a decrease in contrast enhancement in the tumors 
after RT. The shrinkage of the residual neurocytoma began approximately 1 year after 
fractionated RT; this timing corresponds to the endothelial damage caused by irradiation 
which induces the proliferation of smooth muscle cells and the production of extracellular 
collagen by these cells, which leads to progressive stenosis and obliteration of the cAVM 
nidus. In addition, the contractile activity of these gamma ray–activated, spindle–shaped 
smooth muscle cells and the transformation of the resting cells into an activated form after 
irradiation may be relevant to the shrinking process and eventual occlusion of AVMs after 
radiosurgery. The activation of this obliteration mechanism is earlier in pediatric patients 
and young adults than in adults due to the greater number of nonresting cells found in 
young patients' vessels, as reported in an our previous study on cerebral arteriovenous 
malformations (Nicolato et al., 2005). To date, more than 50 patients treated with 
radiosurgery for CN has been described (Table 10). From the neurological point of view, the 
outcome was favourable in most cases. Only in one patient, a radiosurgery-related clinical 
worsening occurred: she was treated with a 6 MV LINAC system for a 8.09 cc left lateral 
ventricle CN. Radiation necrosis and brain edema were developed and ventriculo-peritoneal 
shunt was needed (Martin et al., 2003). The overall survival reported by the different 
authors varies between 67% and 100%, but none of the patients died due to the tumor 
progression. Rades (Rades & Schild, 2006) reviewed the data of all the CN patients reported 
since 1997. There were 21 cases treated with incomplete tumor resection followed by 
stereotactic radiosurgery, GK in 15 and Linac in 6 CNs. The median follow up period was 42 
months. The 5-year actuarial survival and local PFS rates was 100% and 100%, respectively. 
The 4 patients of our series were observed for a median period of 180.6 months. The 10-year 
survival rate was 100%. Local tumor control was achieved in 75% of cases: in only one 
patient, tumor progression was documented at 9.3 months from GKRS. He was operated 
and he was alive and well at last follow-up. In conclusion, we suggest GKRS for residual 
CNs after incomplete resection or early detection of tumor recurrence with relatively small 
volume, which will reduce the long-term risk of radiation injury to the surrounding normal 
brain tissue compared with conventional RT. Because CN tends to show local recurrence 
leading to clinical malignant sequelae such as tumor progression, intracranial hemorrhage, 
or craniospinal dissemination and rarely malignant transformation, we strongly recommend 
GKRS for small residual or recurrent tumors rather than conservative follow up to obtain 
good tumor growth control.  
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Author 
RS dev N° Pt
Me/Med FU 
mos.  
Clinical 
Results  
Perm. 
Sympt. 
    
No def. 
/Impr 
Stable Wors. Compl. 
Matsunaga 
2010 
GK 7 63.6 Me – – – 0.0 
Kim 2007 GK 13 53.7/61.0 – 100.0 – 0.0 
Yen 2007 GK 7 60.0 Me 100.0 – – 0.0 
Lekovic 2007 GK 1 54.0 – 1/1 – 0.0 
Rades 2006 
(reviews) 
GK 
Linac 
15 6 42 Med – – – – 
Martin 2003 Linac 4 33.0/37.5 75.0 – 25.0 25.0 
Javedan 2003 GK 1 25.0 1/1 – – 0.0 
Kim 2003 Linac 1 51.0 – – – 0.0 
Hara 2003 GK 1 12.0 – – – 0.0 
Tyler-Kabara 
2001 
GK 4 45.7/46.0 – 100.0 – 0.0 
Anderson 
2001 
GK 4 16.5/13.0 100.0 – – 0.0 
Bertalanffy 
2001 
GK 3 32.0/24.0 67.0 33.0 – 0.0 
Cobery 2001 GK  4 44.0/32.5 100.0 – – 0.0 
Pollock 2001 GK 1 34.0 1/1 – – 0.0 
Present series GK 4 172.0/180.6 4/4 – – 0.0 
RS dev = Radiosurgical device; N° Pt = number of treated patients; Me = Mean; Med = Median; mos. = 
months; No def./Impr = No pre-GK neurological deficit/Neurological improvement; Wors. = 
Neurological worsening; Perm. Sympt. Compl. = permanent symptomatic complications; GK = Gamma 
Knife; Linac = Linear accelerator. 
Table 10. Clinical data in previous and present series of CN treated with GKRS. 
4.5 Pleomorphic xanthoastrocyroma (PXA) 
PXA is a rare tumor accounting for less than 1% of all astrocytic neoplasms. At MRI, PXA 
does not show peculiar imaging features. This unusual LGPNT of the brain belongs to grade 
II according to WHO classification. Histopathological patterns includes cellular 
pleomorphism, focal eosinophilic protein droplets, and regions with an interstitial reticulin 
fiber network (Figure 8). Maximum surgical removal is considered the first treatment of 
choice. The efficacy of adjuvant radiotherapy has not yet been established, largely because 
of the relative rarity of this disease. Chemotherapy for PXA has been generally considered 
ineffective. The only described case of PXA treated with GKRS showed anaplastic features 
(Koga et al., 2009). Nevertheless, the authors chose to perform radiosurgery on 8 distinct 
intracranial tumor nodules in six different GKRS sessions during a 50 month follow up  
www.intechopen.com
 Gamma Knife Radiosurgery 
 
92
Author N° Ov. Surv. Act. Surv. % Ov.Local Act. Local PFS% 
 Pt % At 5y   At 10y TGC% At 5y      At 10y 
Matsunaga 2010 7 – –             – 87.5 –                  – 
Kim 2007 13 – –             – 84.6 –                  – 
Yen 2007 7 85.7 –             – 88.9 –                  – 
Lekovic 07 1 – –             – 1/1 –                  – 
Rades 2006 (rews.) 156 100.0       100.0          – 95.2 100.0           – 
Martin 2003 4 100.0 –             – 100.0 –                  – 
Javedan 2003 1 1/1 –             – 1/1 –                  – 
Kim 2003 1 1/1 –             – 1/1 –                  – 
Hara 2003 1 1/1 –             – 1/1 –                  – 
Tyler-Kabara 2001 4 100.0 –             – 100.0 –                  – 
Anderson 2001 4 100.0 –             – 100.0 –                  – 
Bertalanffy 2001 3 67.0 –             – 100.0 –                  – 
Cobery 2001 4 100.0 –             – 100.0 –                  – 
Pollock 2001 1 1/1 –             – 1/1 –                  – 
Present series 4 100.0     100.0      100.0 75.0 83.0           83.0 
N° Pt = number of treated patients; Ov. Surv. = overall survival; Act. Surv. = actuarial survival;  
Ov. Local TGC = Overall local tumor growth control; Act. Local PFS = Actuarial local progression-free 
survival. 
Table 11. Radiosurgical outcome in previous and present series of CN. 
 
Fig. 8. PXA. X200 H-E. Presence of pleomorphic bizarre xanthomized cells in a fibrillary 
background. 
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Author 
RS 
dev 
N° 
Pt 
Me/Med FU 
mos.  
Clinical 
Results  
Perm. 
Sympt.  
    
No def. 
/Impr 
Stable Wors. Compl. 
Koga 2009 GK 1 50.0 – – – 0.0 
Present 
series 
GK 3 45.6/43.7 1/3 1/3 1/3‡ 0.0 
RS dev = Radiosurgical device; N° Pt = number of treated patients; Me = Mean; Med = Median;  
mos. = months; No def./Impr = No pre-GK neurological deficit/Neurological improvement; 
Wors. = Neurological worsening; Perm. Sympt. Compl. = permanent symptomatic complications;  
GK = Gamma Knife. 
‡: due to tumor distant progression. 
Table 12. Clinical data in previous and present series of PXA treated with GKRS. 
Author N° Ov. Surv  Act. Surv % Ov. Local Act. Local PFS% 
 Pt % At 5y    At 10y TGC% At 5y       At 10y 
Koga 2009 1 0.0 –            – 100.0 –              – 
Present series 3 66.7‡ 80.0          80.0 66.7 80.0          80.0 
N° Pt = number of treated patients; Ov. Surv. = overall survival; Act. Surv. = actuarial survival;  
Ov. Local TGC = Overall local tumor growth control; Act. Local PFS = Actuarial local progression-free 
survival. 
‡: dead due to tumor local and distant progression. 
Table 13. Radiosurgical outcome in previous and present series of PXA. 
period achieving a successful local control of all treated lesions without radiosurgery-
related permanent side effects. The patient died 66 months after the disease onset; the 
cause of death was  identified with a distant craniospinal axis tumor nodule 
dissemination. In this chapter, we report 3 patients affected with grade II PXA who 
underwent GKRS and followed up for a median period of 43.7 months. To our 
knowledge, this is the only reported "small" series of low-grade PXA treated with GKRS. 
One patient affected with a brain stem PXA died at 22.1 months from GKRS due to local 
and distant tumor progression. In the other 2 cases, a long term PFS was achieved and 
they are well and alive at last follow up performed at 43.7 months and 70.9 months from 
radiosurgical treatment.  
4.6 Others (Miscellaneous) 
This heterogeneous group of patients is represented by different histological types of 
extremely unusual LGPNT of the brain: gangliolgioma, mixed oligoastrocytoma, 
subependymoma, and papillary glioneuronal tumor. The results of our experience with 
GKRS is excellent: negative or stable neurologic conditions in all cases, no radiosurgery-
related complications, 100% survival and local TGC rate. Obviously, other experiences with 
GKRS on such rare tumors are limited or even absent (Tables 14 and 15). In the few reported 
cases, the authors described encouraging responses to radiosurgery, as well. The results 
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seems to be particularly encouraging when GKRS is employed. To our knowledge, there are 
no other patients affected with papillary glioneuronal tumor who underwent GKRS 
reported in the literature; therefore, the case of the present series represents the first 
papillary glioneuronal tumor treated with radiosurgery. 
 
Histology Author RS N°  
FU 
mos.  
Clinical 
Results  
Perm. 
Sympt.  
 
 
dev Pt  No def. 
/Impr 
Stable Wors. Compl. 
Ganglioglioma 
Kim  
1999 
GK 1 14.0 – – – 0.0 
 
Schröttner 
2002 
GK 3 – – – – – 
 
Present 
series 
GK 2 68.4 –        2/2 – 0.0 
         
Subependymoma 
Ecker  
2004 
GK 1 54.0 –        1/1 – 0.0 
 
Seol  
2003 
Lin 1 24 –        – – 0.0 
 Im 2003 
GK 
Lin
2 22.5 –        – – 0.0 
 
Roos  
2000 
Lin 1 16 1/1 – – 0.0 
 
Present 
series 
GK 1 31.2 1/1 – – 0.0 
         
Oligoastrocytoma 
Sarkar  
2002 
GK 11 les –      – – –      0.0 
 
Present 
series 
GK 1 68.3 1 – –      0.0       
         
Papillary Gl. 
Tumour 
Present 
series 
GK 1 104.0 1/1 – –      0.0       
RS dev = Radiosurgical device; N° Pt = number of treated patients; mos. = months; No def./Impr = No 
pre-GK neurological deficit/Neurological improvement; Wors. = Neurological worsening; Perm. 
Sympt. Compl. = permanent symptomatic complications; GK = Gamma Knife; Lin = Linear accelerator;  
les = lesions; Papillary Gl. Tumour = Papillary Glioneuronal Tumour. 
Table 14. Clinical data in previous and present series of rare unusual LGPNTs treated with 
GKRS. 
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Histology Author RS dev N° Pt
Ov. 
Surv.
Ov. Local 
TGC% 
Act. 
Local 
PFS% 
Prognostic 
Factors 
 At 5y  
Ganglioglioma Kim 1999 GK 1 – 
1/1 solid 
compon.
–         – 
 
Schröttner 
2002 
GK 3     
 
Present 
series 
GK 2 2/2 2/2 –         None 
  
Subependymoma Ecker 2004 GK 1 1/1 1/1 –         – 
 Seol 2003 Lin 1 1/1 0/1 –         – 
 Im 2003 GKLin 2 2/2 0/2 –         – 
 Roos 2000 Lin 1 1/1 1/1 –         –            
 
Present 
series
GK 1 1/1 1/1 –         None 
  
Oligoastrocytoma Sarkar 2002 GK 11 les –     – 42.0      
Younger age  
Smaller TVs 
 
Present 
series 
GK 1 1/1 1 100.0     None 
  
Papillary Gl. 
Tumour 
Present 
series
GK 1 1/1 1/1 100.0     None 
RS dev = Radiosurgical device; N° Pt = number of treated patients; Ov. Surv. = Overall survival;  
Ov. Local TGC = Overall local tumor growth control; Act. Local PFS = Actuarial local progression-free 
survival; GK = Gamma Knife; compon. = component; Lin = Linear accelerator; TVs = Tumor volumes. 
Table 15. Radiosurgical outcome in previous and present series of rare unusual LGPNTs. 
4.7 Future research/perspectives 
The results described with the GKRS treatment in such unusual LGPNTs are very intersting. 
Nevertheless, the need for further future perspectives and researches emerge from all these 
studies. First of all, the application of multisession GKRS with the Extend system (Elekta 
instruments, AB) on larger TVs with the aim of increasing the local TGC without exposing 
the patients to higher risk of radiation toxicity on the surrounding normal brain tissue need 
to be studied. Second, it should be interesting to investigate if there is any potential 
correlation between biomarker expression (Ki67, MGMT, PCNA, p53, etc.) in such unusual 
LGPNTs and GKRS outcome. Finally, basing on the literature data and our experience 
results, it should be suitable that GKRS is included in the international guidelines for good 
clinical practice as part of the therapeutic armamentarium for the management of unusual 
LGPNTs, particularly as concerns pineocytoma and CN.  
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5. Conclusion 
GKRS may be already considered an effective and safe treatment alternative in 
multimodality approach for selected cases with pineocytoma and CNs, thus eliminating the 
need for reoperation of residual or recurrent tumors and avoiding the potential long-term 
side effects of conventional RT in these young adult patients. In the unusual LGPNTs with a 
limited number of treated  patients – CPP, PXA, and other rare tumors – radiosurgery seems 
to be a valid complementary treatment tool in these rarer tumors, also. Nevertheless, 
multidisciplinary studies on large series of patients and long follow-up period with 
statistical analysis are needed to convincingly demonstrate the efficacy and safety of GKRS 
on such primary low-grade brain tumors. 
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